Exhibits
S-4
from S-4
160 pages
Inverness Medical Innovations, Inc.
02/12/10
EX-4.14
from S-4
7 pages
Fourth Supplemental Indenture (This “Supplemental Indenture”), Dated as of November 25, 2009, Among Free & Clear, Inc. and Tapestry Medical, Inc. (Collectively, the “New Guarantors”), Subsidiaries of Inverness Medical Innovations, Inc. (Or Its Successor) (The “Issuer”), Inverness Medical Innovations, Inc., a Delaware Corporation, Each of the Guarantors (The “Existing Guarantors”) Under the Indenture Referred to Below, and the Bank of New York Mellon Trust Company, N.A., as Trustee Under the Indenture Referred to Below (The “Trustee”)
02/12/10
EX-4.15
from S-4
7 pages
Fifth Supplemental Indenture (This “Supplemental Indenture”), Dated as of November 25, 2009, Among Free & Clear, Inc. and Tapesty Medical, Inc. (Collectively, the “New Guarantors”), Subsidiaries of Inverness Medical Innovations, Inc. (Or Its Successor) (The “Issuer”), Inverness Medical Innovations, Inc., a Delaware Corporation, Each of the Guarantors (The “Existing Guarantors”) Under the Indenture Referred to Below, and the Bank of New York Mellon Trust Company, N.A., as Trustee Under the Indenture Referred to Below (The “Trustee”)
02/12/10
EX-4.16
from S-4
7 pages
Sixth Supplemental Indenture (This “Supplemental Indenture”), Dated as of January 29, 2010, Among Rmd Networks, Inc. (The “New Guarantor”), a Subsidiary of Inverness Medical Innovations, Inc. (Or Its Successor) (The “Issuer”), Inverness Medical Innovations, Inc., a Delaware Corporation, Each of the Guarantors (The “Existing Guarantors”) Under the Indenture Referred to Below, and the Bank of New York Mellon Trust Company, N.A., as Trustee Under the Indenture Referred to Below (The “Trustee”)
02/12/10
EX-4.17
from S-4
7 pages
Seventh Supplemental Indenture (This “Supplemental Indenture”), Dated as of January 29, 2010, Among Rmd Networks, Inc. ( the “New Guarantor”), Subsidiary of Inverness Medical Innovations, Inc. (Or Its Successor) (The “Issuer”), Inverness Medical Innovations, Inc., a Delaware Corporation, Each of the Guarantors (The “Existing Guarantors”) Under the Indenture Referred to Below, and the Bank of New York Mellon Trust Company, N.A., as Trustee Under the Indenture Referred to Below (The “Trustee”)
02/12/10
EX-5.1
from S-4
5 pages
Ex-5.1 Form of Opinion of Foley Hoag Llp
02/12/10
EX-5.2
from S-4
4 pages
Ex-5.2 Form of Opinion of Perkins Coie Llp
02/12/10
EX-5.3
from S-4
3 pages
Ex-5.3 Form of Opinion of Perkins Coie Llp
02/12/10
EX-5.4
from S-4
4 pages
Ex-5.4 Form of Opinion of Greenberg Traurig P.A.
02/12/10
EX-5.5
from S-4
4 pages
Ex-5.5 Form of Opinion of Greenberg Traurig Llp
02/12/10
EX-5.6
from S-4
3 pages
Ex-5.6 Form of Opinion of Troutman Sanders Llp
02/12/10
EX-5.7
from S-4
4 pages
Ex-5.7 Form of Opinion of Venable Llp
02/12/10
EX-12.1
from S-4
~5
pages
Ex-12.1 Statement Regarding Computation of Ratio of Earnings to Fixed Charges
02/12/10
EX-12.2
from S-4
~5
pages
Ex-12.2 Statement Regarding Computation of Ratio of Earnings to Combined Fixed Charges and Preference Dividends
02/12/10
EX-23.1
from S-4
1 page
Ex-23.1 Consent of Bdo Seidman, Llp
02/12/10
EX-23.2
from S-4
1 page
Ex-23.2 Consent of Kpmg Llp
02/12/10
EX-23.3
from S-4
1 page
Ex-23.3 Consent of Ernst & Young Llp
02/12/10
EX-23.4
from S-4
1 page
Ex-23.4 Consent of Grant Thornton Zhongua
02/12/10
EX-23.5
from S-4
1 page
Ex-23.5 Consent of Stonefield Josephson, Inc.
02/12/10
EX-25.1
from S-4
8 pages
Ex-25.1 Statement of Eligibility
02/12/10
EX-99.1
from S-4
20 pages
Ex-99.1 Form of Letter of Transmittal
02/12/10
EX-99.2
from S-4
5 pages
Ex-99.2 Form of Notice Guaranteed Delivery
02/12/10
EX-99.3
from S-4
3 pages
Inverness Medical Innovations, Inc
02/12/10
EX-99.4
from S-4
4 pages
Ex-99.4 Form of Letter to Clients
02/12/10
